1.41
price up icon7.63%   +0.10
after-market  After Hours:  1.48  0.07   +4.96%
loading

Passage Bio Inc Stock (PASG) Forecast

The Passage Bio Inc (PASG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.8818, representing a +246.22% increase from the current price of $1.41. The highest analyst price target is $4.3762, and the lowest is $5.3873.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PASG Price Target
Average 9.673 (+586.03% Upside)
loading

Is Passage Bio Inc (PASG) A Buy Now?

Oscillators
Name Value Action
RSI(14) 58.06 Neutral
STOCH(9,6) 85.49 Sell
STOCHRSI(14) 100.00 Sell
MACD(12,26) 0.00423 Buy
ADX(14) 15.03 Neutral
William %R -11.45 Sell
CCI(14) 138.46 Buy
Buy: 2 Sell: 3 Neutral: 2
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
1.301
Buy
1.3153
Buy
MA20
1.276
Buy
1.3041
Buy
MA50
1.3839
Buy
1.2865
Buy
MA100
1.1803
Buy
1.1905
Buy
MA200
0.9488
Buy
1.1099
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, PASG could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on PASG, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 58.06 indicates that PASG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 85.49 indicates that PASG is oversold. This means that PASG price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that PASG is oversold. This suggests that PASG price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 15.03 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 138.46 indicates that PASG is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term PASG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Passage Bio Inc financial reports and earnings history, Passage Bio Inc (PASG) stock could reach $6.4619 by 2030, $46.68 by 2040 and $68.87 by 2050. See the projected annual prices until 2050 of the Passage Bio Inc stock below:

  • Passage Bio Inc (PASG) is expected to reach an average price of $30.42 in 2035, with a high prediction of $29.87 and a low estimate of $29.08. This indicates an $2,057% rise from the last recorded price of $1.41.
  • Passage Bio Inc (PASG) stock is projected to chart a bullish course in 2040, with an average price target of $45.44, representing an $3,122% surge from its current level. The forecast ranges from a conservative $45.67 to a sky-high $46.68.
  • Our analysts predict Passage Bio Inc (PASG) to jump 4,009% by 2045, soaring from $58.21 to an average price of $57.93, potentially reaching $58.13. While $58.21 is the low estimate, the potential upside is significant.
  • Passage Bio Inc (PASG) stock is expected to climb by 2050, reaching an average of $69.49, a $4,828% jump from its current level. However, a wide range of estimates exists, with high and low targets of $68.87 and $69.98, respectively, highlighting the market's uncertainty.

Passage Bio Inc Stock (PASG) Year by Year Forecast

Passage Bio Inc Stock (PASG) Price Forecast for 2024

Our forecast for PASG stock price in 2024 now indicates an average price target of $9.7851 with a high forecast of $18.88 and a low forecast of $0.69. The average prediction reflects an increase of +593.98% from the last recorded price of $1.41.
Month Average Low High Change from today's price
June, 2024 $3.2173 $5.3873 $4.3762 +128.18%
July, 2024 $0.4175 $2.6025 $1.9814 -70.39%
August, 2024 $3.7234 $0.8554 $6.7384 +164.07%
September, 2024 $8.0592 $2.8423 $18.88 +471.57%
October, 2024 $3.236 $1.4661 $9.0982 +129.50%
November, 2024 $2.5402 $4.417 $3.3991 +80.15%
December, 2024 $2.4343 $2.1712 $1.5333 +72.65%

Passage Bio Inc Stock (PASG) Price Forecast for 2025

Passage Bio Inc Stock (PASG) is expected to reach an average price of $7.0902 in 2025, with a high prediction of $14.13 and a low estimate of $0.0545. This indicates an +402.85% rise from the last recorded price of $1.41.
Month Average Low High Change from today's price
January, 2025 $0.0595 $2.8195 $4.3164 -95.78%
February, 2025 $0.7037 $1.1916 $0.8294 -50.09%
March, 2025 $7.5522 $0.4658 $7.5722 +435.61%
April, 2025 $10.60 $6.6111 $12.84 +651.56%
May, 2025 $5.0728 $1.6688 $14.13 +259.77%
June, 2025 $3.6386 $0.6397 $6.8507 +158.06%
July, 2025 $1.1734 $0.0545 $6.0866 -16.78%
August, 2025 $3.2793 $0.1036 $4.3593 +132.57%
September, 2025 $1.9149 $0.1178 $3.7082 +35.81%
October, 2025 $1.5301 $0.888 $1.4185 +8.52%
November, 2025 $1.7242 $0.8911 $1.4489 +22.29%
December, 2025 $2.1594 $2.7363 $2.1284 +53.15%

Passage Bio Inc Stock (PASG) Price Forecast for 2026

The predicted value for Passage Bio Inc (PASG) in 2026 is set at an average of $5.4739. Estimates vary from a peak of $8.5573 to a trough of $2.3905, indicating an +288.22% surge from the present price of $1.41.
Month Average Low High Change from today's price
January, 2026 $2.0836 $2.3905 $1.8826 +47.77%
February, 2026 $4.0778 $3.4046 $3.2767 +189.20%
March, 2026 $3.5419 $4.2388 $4.0909 +151.20%
April, 2026 $5.5371 $4.913 $4.8771 +292.70%
May, 2026 $6.0513 $5.7282 $5.6913 +329.17%
June, 2026 $7.3754 $6.7323 $6.9154 +423.08%
July, 2026 $8.2506 $7.3065 $7.9956 +485.15%
August, 2026 $8.1348 $8.3217 $8.3038 +476.94%
September, 2026 $8.09 $7.849 $8.0058 +473.76%
October, 2026 $8.8342 $8.421 $8.4805 +526.54%
November, 2026 $8.1283 $8.5983 $8.5573 +476.48%
December, 2026 $7.5735 $7.6435 $7.7804 +437.13%

Passage Bio Inc Stock (PASG) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Passage Bio Inc (PASG) is $6.1661, with a high forecast of $7.4746 and a low forecast of $4.8576. This indicates an +337.31% increase from the last price of $1.41.
Month Average Low High Change from today's price
January, 2027 $7.7677 $7.5746 $7.4177 +450.90%
February, 2027 $7.3118 $7.3318 $7.2687 +418.57%
March, 2027 $7.647 $7.2639 $7.307 +442.34%
April, 2027 $7.3512 $7.4212 $7.4746 +421.36%
May, 2027 $6.8354 $7.1743 $7.1333 +384.78%
June, 2027 $6.8306 $6.8095 $6.7685 +384.44%
July, 2027 $5.7047 $6.1747 $6.4626 +304.59%
August, 2027 $5.8089 $5.8689 $5.7489 +311.98%
September, 2027 $5.6441 $5.7041 $5.6734 +300.29%
October, 2027 $5.5182 $5.5382 $5.4272 +291.36%
November, 2027 $5.2673 $5.2674 $5.3293 +273.57%
December, 2027 $4.8319 $4.8576 $5.0434 +242.69%

Passage Bio Inc Stock (PASG) Price Forecast for 2028

In 2028, Passage Bio Inc (PASG) is projected to reach an average price of $2.6051, with a high projection of $4.7186 and a low estimate of $0.4917. This indicates an +84.76% rise from the last price of $1.41.
Month Average Low High Change from today's price
January, 2028 $4.5702 $4.6315 $4.7186 +224.13%
February, 2028 $4.2109 $4.3059 $4.4928 +198.65%
March, 2028 $4.006 $4.0211 $4.0869 +184.11%
April, 2028 $3.7313 $3.7353 $3.8933 +164.63%
May, 2028 $3.4606 $3.5003 $3.6119 +145.43%
June, 2028 $3.1546 $3.1646 $3.3125 +123.73%
July, 2028 $2.8588 $2.8947 $2.9957 +102.75%
August, 2028 $2.0978 $2.3629 $2.6724 +48.78%
September, 2028 $1.8692 $1.9076 $1.935 +32.57%
October, 2028 $1.4548 $1.4823 $1.7192 +3.18%
November, 2028 $0.6075 $0.5465 $1.0433 -56.91%
December, 2028 $0.3117 $0.4917 $0.4385 -77.90%

Passage Bio Inc Stock (PASG) Price Forecast for 2029

The 2029 price forecast for Passage Bio Inc Stock (PASG) is $13.23 on average, with a high prediction of $26.38 and a low estimate of $0.0739. This represents an +837.95% increase from the previous price of $1.41.
Month Average Low High Change from today's price
January, 2029 $0.1441 $0.0739 $0.2142 -89.78%
February, 2029 $31.44 $21.54 $26.38 +2,130%
March, 2029 $23.51 $25.68 $24.75 +1,568%
April, 2029 $22.07 $23.16 $21.96 +1,465%
May, 2029 $15.86 $17.28 $18.63 +1,025%
June, 2029 $11.21 $11.54 $12.69 +695.15%
July, 2029 $20.92 $12.73 $15.81 +1,384%
August, 2029 $21.10 $22.48 $22.04 +1,396%
September, 2029 $20.68 $20.65 $19.86 +1,367%
October, 2029 $17.91 $20.67 $22.40 +1,170%
November, 2029 $18.24 $18.88 $17.98 +1,193%
December, 2029 $9.6657 $13.85 $17.41 +585.51%

Passage Bio Inc Stock (PASG) Price Forecast for 2030

Passage Bio Inc Stock (PASG) is expected to reach an average price of $12.61 in 2030, with a high forecast of $17.28 and a low forecast of $7.9382. This signifies an +794.32% surge from the last price of $1.41.
Month Average Low High Change from today's price
January, 2030 $6.2261 $8.3198 $6.4619 +341.57%
February, 2030 $11.43 $7.9382 $11.06 +710.95%
March, 2030 $12.55 $12.62 $11.92 +790.26%
April, 2030 $14.27 $12.96 $14.00 +912.13%
May, 2030 $12.20 $14.02 $13.77 +765.35%
June, 2030 $17.08 $14.59 $15.56 +1,111%
July, 2030 $16.30 $15.82 $16.50 +1,056%
August, 2030 $16.18 $15.58 $15.64 +1,047%
September, 2030 $16.97 $17.03 $16.27 +1,103%
October, 2030 $15.83 $16.37 $15.95 +1,022%
November, 2030 $17.51 $17.07 $16.78 +1,142%
December, 2030 $16.65 $17.58 $17.28 +1,081%
$82.10
price down icon 0.41%
$162.48
price up icon 0.14%
$29.03
price down icon 2.32%
$151.22
price down icon 0.73%
$93.35
price up icon 0.68%
$393.78
price up icon 1.44%
Cap:     |  Volume (24h):